Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $3.11 earnings per share for the quarter, Zacks reports. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The business had revenue of $638.48 million during the quarter.
Bio-Rad Laboratories Price Performance
Shares of NYSE BIO.B traded up $32.55 during midday trading on Friday, reaching $326.78. 119 shares of the stock traded hands, compared to its average volume of 1,084. The company’s 50 day moving average is $285.57 and its 200 day moving average is $305.53. Bio-Rad Laboratories has a one year low of $271.00 and a one year high of $373.78. The stock has a market capitalization of $9.32 billion, a PE ratio of -31.54 and a beta of 0.72. The company has a debt-to-equity ratio of 0.13, a current ratio of 6.57 and a quick ratio of 4.89.
Bio-Rad Laboratories Company Profile
Read More
- Five stocks we like better than Bio-Rad Laboratories
- Bank Stocks – Best Bank Stocks to Invest In
- Should You Invest in Bitcoin? Pros and Cons
- Why is the Ex-Dividend Date Significant to Investors?
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- What Are Dividend Achievers? An Introduction
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.